Wasting and sudden cardiac death in hemodialysis patients: a post hoc analysis of 4D (Die Deutsche Diabetes Dialyse Studie).

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American Journal of Kidney Diseases

• Publication date

  2011-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/j.ajkd.2011.05.026PMID 21820222
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Uremic cardiomyopathy and insulin resistance: a critical role for akt?

  2011cited by this paper
• The emerging pleiotrophic role of adipokines in the uremic phenotype

  2010cited by this paper
• Longitudinal arrhythmogenic remodelling in a mouse model of longstanding pressure overload

  2010cited by this paper
• Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study).

  2010cited by this paper
• Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patients.

  2009cited by this paper
• The current status of interventions aiming at reducing sudden cardiac death in dialysis patients.

  2009cited by this paper
• Metabolic abnormalities in chronic kidney disease that contribute to cardiovascular disease, and nutritional initiatives that may diminish the risk

  2009cited by this paper
• Glycemic Control and Cardiovascular Events in Diabetic Hemodialysis Patients

  2009cited by this paper
• Subjective global assessment of nutritional status is strongly associated with mortality in chronic dialysis patients.

  2009cited by this paper
• Atheroma progression in chronic kidney disease.

  2009cited by this paper
• Prevention of sudden cardiac death: rationale and design of the Implantable Cardioverter Defibrillators in Dialysis patients (ICD2) Trial – a prospective pilot study

  2008cited by this paper
• Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients.

  2008cited by this paper
• NON‐CORONARY HEART DISEASE IN DIALYSIS PATIENTS: Sudden Cardiac Death and Dialysis Patients

  2008cited by this paper
• The challenge of sudden death in dialysis patients.

  2008cited by this paper
• Coronary heart disease Change in N-terminal-proB-type-natriuretic-peptide and the risk of sudden death , stroke , myocardial infarction , and all-cause mortality in diabetic dialysis patients

  2008cited by this paper
• Nuclear factor-kappa B signaling in skeletal muscle atrophy

  2008cited by this paper
• The association of sudden cardiac death with inflammation and other traditional risk factors.

  2008cited by this paper
• A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease.

  2008cited by this paper
• Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients.

  2007cited by this paper
• Baroreflex effectiveness index and baroreflex sensitivity predict all-cause mortality and sudden death in hypertensive patients with chronic renal failure

  2007cited by this paper
• Basic Science and Dialysis: Disturbances of Acquired Immunity in Hemodialysis Patients

  2007cited by this paper
• Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up.

  2007cited by this paper
• Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy.

  2006cited by this paper
• Sudden cardiac death and acute myocardial infarction in dialysis patients: perspectives of a cardiologist.

  2005cited by this paper
• Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

  2005cited by this paper
• Survival advantages of obesity in dialysis patients.

  2005cited by this paper
• POOR NUTRITIONAL STATUS AND INFLAMMATION: Metabolic Acidosis and Malnutrition‐Inflammation Complex Syndrome in Chronic Renal Failure

  2004cited by this paper
• Randomized Controlled Trial on the Efficacy and Safety of Atorvastatin in Patients with Type 2 Diabetes on Hemodialysis (4D Study): Demographic and Baseline Characteristics

  2004cited by this paper
• Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

  2004cited by this paper
• Inflammation and nutrition in renal insufficiency.

  2003cited by this paper
• Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences.

  2003cited by this paper
• Immunological basis of inflammation in dialysis.

  2002cited by this paper
• The malnutrition, inflammation, and atherosclerosis (MIA) syndrome -- the heart of the matter.

  2002cited by this paper
• C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation

  2001cited by this paper
• A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients.

  2001cited by this paper
• Inflammatory and Atherosclerotic Interactions in the Depleted Uremic Patient

  2000cited by this paper
• QT dispersion in patients with end-stage renal failure and during hemodialysis.

  1999cited by this paper
• Prognostic value of heart rate variability during long-term follow-up in chronic haemodialysis patients with end-stage renal disease.

  1999cited by this paper
• Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women.

  1998cited by this paper
• Autonomic dysregulation in patients awaiting kidney transplantation.

  1998cited by this paper
• Cardiac disease in chronic uremia: pathophysiology.

  1997cited by this paper
• Electrophysiologic Effects of Interactions Between Activated Canine Neutrophils and Cardiac Myocytes

  1997cited by this paper
• Arrhythmias Caused by Platelet Activating Factor

  1996cited by this paper
• Effect of malnutrition and uremia on impaired cellular host defence.

  1992cited by this paper
• Cardiac effects of caloric restriction-mechanisms and potential hazards.

  1992cited by this paper

• QT-Prolonging Medications: Prevalence of Use and Associated Risks in CKD.

  2025cites this paper
• Weighing the pros and cons of opioids in renal patients with protein-energy wasting: the triaging potential of frailty

  2023cites this paper
• Criteria for classification of protein–energy wasting in dialysis patients: impact on prevalence

  2019cites this paper
• Diagnostic Usefulness of the Protein Energy Wasting Score in Prevalent Hemodialysis Patients.

  2018cites this paper
• Acid-Base and Electrolyte Managements in Chronic Kidney Disease and End-Stage Renal Disease: Case-Based Discussion

  2018cites this paper
• Lipid-Lowering Therapy in CKD: Should We Use It and in Which Patients

  2017cites this paper
• Cardiovascular disease risk in patients receiving organ transplantation: a national cohort study

  2017cites this paper
• Sudden cardiac death in haemodialysis: clinical epidemiology and mechanisms.

  2016cites this paper
• [Cardiac arrest in dialysis patients: Risk factors, preventive measures and management in 2015].

  2016cites this paper
• Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study.

  2016cites this paper
• Impact of serum potassium on therapeutic prognosis of maintenance hemodialysis patients on angiotensin receptor antagonists

  2016cites this paper
• Cardiovascular complications in chronic dialysis patients

  2016cites this paper
• Appetite and Gastrointestinal Symptoms in End Stage Renal Disease Patients

  2016cites this paper
• Arrhythmia and Sudden Death in Hemodialysis Patients: Protocol and Baseline Characteristics of the Monitoring in Dialysis Study.

  2016cites this paper
• The effects of resistance exercise and oral nutritional supplementation during hemodialysis on indicators of nutritional status and quality of life.

  2016cites this paper
• The Obesity Paradox and the Role of Inflammation.

  2016cites this paper
• Valoración del estado nutricional en los diferentes estadios de la enfermedad renal crónica y su relación con el estrés oxidativo y la inflamación

  2015cites this paper
• Lipids and Chronic Kidney Disease Clinical Trials: A Critical Appraisal

  2015cites this paper
• Neurotherapeutic effect of allopurinol against brain injury in hyperlipidemic rats

  2015cites this paper
• Defining protein-energy wasting syndrome in chronic kidney disease: prevalence and clinical implications.

  2014cites this paper
• Longitudinal Assessments of Erythropoietin-Stimulating Agent Responsiveness and the Association with Specific Clinical Outcomes in Dialysis Patients

  2014cites this paper
• Low serum sodium is associated with protein energy wasting and increased interdialytic weight gain in haemodialysis patients

  2014cites this paper
• Pathophysiologic and Treatment Strategies for Cardiovascular Disease in End-Stage Renal Disease and Kidney Transplantations

  2014cites this paper
• Definiendo el síndrome de desgaste proteico energético en la enfermedad renal crónica: prevalencia e implicaciones clínicas

  2014cites this paper
• Management Considerations for the Hospitalist Caring for Patients with End-Stage Renal Disease

  2013cites this paper
• Fatty Acids and Other Risk Factors for Sudden Cardiac Death in Patients Starting Hemodialysis

  2013cites this paper
• Effect of folic acid and vitamin B12 on the expression of PPARγ, caspase-3 and caspase-8 mRNA in the abdominal aortas of rats with hyperlipidemia

  2013cites this paper
• The impact of serum potassium on mortality in chronic hemodialysis patients

  2013cites this paper
• Predicting erythropoietin resistance in hemodialysis patients with type 2 diabetes

  2013cites this paper
• Treatment of dyslipidemia in chronic kidney disease: Effectiveness and safety of statins.

  2012cites this paper
• Expect the unexpected: sudden cardiac death in dialysis patients.

  2012cites this paper
• Apolipoprotein A‐IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus – a post hoc analysis of the 4D Study

  2012cites this paper